Compounders Research Compare

Satellos Bioscience Inc.(MSLE)

Biotechnology · Toronto, ON

$8.12+0.06 (+0.81%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Toronto, ON

18 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Francis Gleeson

View full financials

Satellos Bioscience (MSLE) Price/FCF Ratio: History & Chart | TGMCharts

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T16:13:10.851Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:13:10.851Z.

Quote observation: 2026-10-06T16:10:08.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 10,454,100
TTM free cash flow · period ending 2026-06-30: -28,676,071

FMP input reference: a92f25166a0617989281a7eefd332dc08894ee274fcedbd674fe1a92e2c9d78d

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MSLE Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

MSLE Competitors' Price/FCF Ratio

Satellos Bioscience Inc.

Current

Market Cap

$10.45M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Polyrizon Ltd.

Market Cap

$10.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Caring Brands, Inc.

Market Cap

$10.68M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CytoMed Therapeutics Limited

Market Cap

$11.00M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NeuroOne Medical Technologies Corporation

Market Cap

$10.01M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MetaVia Inc.

Market Cap

$9.68M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Medicus Pharma Ltd. Common Stock

Market Cap

$10.06M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lisata Therapeutics, Inc.

Market Cap

$10.75M

Price/FCF Ratio

N/A

TTM Avg

5.33

3Y Avg

5.33

5Y Avg

5.33

Lifeward Ltd.

Market Cap

$9.92M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BioVie Inc.

Market Cap

$11.09M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Satellos Bioscience Inc. (MSLE)	$10.45M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.54M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.68M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
NeuroOne Medical Technologies Corporation (NMTC)vs ›	$10.01M	N/A	N/A	N/A	N/A
MetaVia Inc. (MTVA)vs ›	$9.68M	N/A	N/A	N/A	N/A
Medicus Pharma Ltd. Common Stock (MDCX)vs ›	$10.06M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.75M	N/A	5.33	5.33	5.33
Lifeward Ltd. (LFWD)vs ›	$9.92M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.09M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics